United Health Products (United Health Products) Effective Interest Rate on Debt % : 13.83% (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is United Health Products Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. United Health Products's annualized positive value of Interest Expense for the quarter that ended in Mar. 2024 was $0.11 Mil. United Health Products's average total debt for the quarter that ended in Mar. 2024 was $0.78 Mil. Therefore, United Health Products's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2024 was 13.83%.

United Health Products Effective Interest Rate on Debt % Historical Data

The historical data trend for United Health Products's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Health Products Effective Interest Rate on Debt % Chart

United Health Products Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

230.91

117.93

158.66

17.42

15.76

United Health Products Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															16.17	15.01	17.73	12.76	13.83

Competitive Comparison of United Health Products's Effective Interest Rate on Debt %

For the Medical Instruments & Supplies subindustry, United Health Products's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

United Health Products's Effective Interest Rate on Debt % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, United Health Products's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where United Health Products's Effective Interest Rate on Debt % falls into.

United Health Products Effective Interest Rate on Debt % Calculation

United Health Products's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2022 )	+	Total Debt (A: Dec. 2023 ))	/ count )
=	-1 * -0.116	/	( (0.688	+	0.784)	/ 2 )
=	-1 * -0.116	/	0.736
=	15.76 %

where

	Total Debt (A: Dec. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0.688
=	0.688

	Total Debt (A: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.048	+	0.736
=	0.784

United Health Products's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Dec. 2023 )	+	Total Debt (Q: Mar. 2024 ))	/ count )
=	-1 * -0.108	/	( (0.784	+	0.778)	/ 2 )
=	-1 * -0.108	/	0.781
=	13.83 %

where

	Total Debt (Q: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.048	+	0.736
=	0.784

	Total Debt (Q: Mar. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.04	+	0.738
=	0.778

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

United Health Products (OTCPK:UEEC) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

United Health Products Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of United Health Products's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

United Health Products (United Health Products) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » United Health Products Inc (OTCPK:UEEC) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

N/A

Address

526 Commerce Circle, Suite No. 120, Mesquite, NV, USA, 89027

Website

https://www.uhpcorp.com

United Health Products Inc is a US-based company. It mainly manufactures and markets a patented hemostatic gauze for the healthcare and wound care sectors. The company's product HemoStyp is derived from regenerated oxidized cellulose, which is naturally designed to absorb exudate from superficial wounds and helps control bleeding. It markets its product to dental and medical markets as well as, sports, military and veterinary sectors, and others. The company's trademarks include Boo Boo Strips; The Ultimate Bandage; Hemostrips; CelluSTAT and Nik Fix.

Executives

Brian David Thom	officer: CEO	10624 S EASTERN AVE., STE A209, HENDERSON NV 89052
Kristofer Heaton	officer: Vice-President Finance, CFO	526 COMMERCE CIRCLE, STE 120, MESQUITE NV 89027
Nate Knight	director	C/O MORSE & MORSE, PLLC, 1400 OLD COUNTRY ROAD, SUITE 302, WESTBURY NY 11590
Louis Schiliro	officer: Chief Operating Officer	10624 S. EASTERN AVENUE, STE. A209, HENDERSON NV 89052
Douglas K Beplate	officer: CEO
Robert J. Denser	director	10624 S. EASTERN AVE., STE. A209, HENDERSON NV 89052
John Vito Capotorto	director	1090 KING GEORGES POST ROAD, SUITE 501, EDISON NJ 08837
Sherman Lazrus	director
Rodney Paul Leibowitz	director	420 EAST 54TH STREET, APARTMENT 15B, NEW YORK NY 10022
Michael R. Wiechnik	director	11 PRESWICK DR., MEDFORD NJ 08055
Richard Rifenburgh	director	2637 E. ATLANTIC BLVD., #133, POMPANO BEACH FL 33062
Phillip David Forman	director, officer: President, Chairman and CEO	1090 KING GEORGES POST RD,501, EDISON NJ 08837
Jan E Chason	director, officer: Chief Financial Officer	120 WALL STREET, SUITE 2401, NEW YORK NY 10005
Kelly Thomas Hickel	director, officer: Chief Executive Officer	1630A 30TH STREET, SUITE 300, BOULDER CO 80301
Patrick Donelan	10 percent owner	3570 LAKEVIEW DRIVE, DELRAY BEACH FL 33445